Scinovex
review Open Access

Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion

Cochrane Database of Systematic Reviews · 2011 · pp. CD001886–CD001886
David HenryPaul A CarlessAnnette MoxeyDianne L. O’ConnellBarrie StokesDean A FergussonKatharine Ker

Abstract

Anti-fibrinolytic drugs provide worthwhile reductions in blood loss and the receipt of allogeneic red cell transfusion. Aprotinin appears to be slightly more effective than the lysine analogues in reducing blood loss and the receipt of blood transfusion. However, head to head comparisons show a lower risk of death with lysine analogues when compared with aprotinin. The lysine analogues are effective in reducing blood loss during and after surgery, and appear to be free of serious adverse effects.

Blood transfusion and managementTrauma, Hemostasis, Coagulopathy, ResuscitationCardiac and Coronary Surgery TechniquesMedicineAprotininBlood managementPerioperativeIntensive care medicineBlood lossBlood transfusionSurgery

MeSH terms

AdultAntifibrinolytic AgentsHumansAprotininTranexamic AcidTransplantation, HomologousAminocaproic AcidRandomized Controlled Trials as TopicBlood Loss, SurgicalErythrocyte Transfusion
Citations
1,069
FWCI
field-weighted impact
References
401
Percentile
vs. same field & year
Citations per year
References
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.